Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Natera, Inc. - Common Stock
(NQ:
NTRA
)
173.39
+2.66 (+1.56%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Natera, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
The S&P 500 Fights Through Challenging Headlines To Close At New Weekly All-Time Highs
February 14, 2025
In this video lesson, I review the resilient overall market, stocks on my radar for the short and long-term portfolio, and a new EOD swing trade, for Tuesday's session. Happy trading. Aloha.
Via
Talk Markets
Topics
Stocks
Stocks / Equities
Exposures
US Equities
$100 Invested In Natera 5 Years Ago Would Be Worth This Much Today
February 06, 2025
Via
Benzinga
Small- To Mid-Cap Biotech Trades Poised For Gains
February 01, 2025
On Monday, we called for a trading bottom in healthcare stocks. We also saw momentum picking for two Health Science sectors: small- to mid-cap biotechs, and MedTech. Here is a closer look at these...
Via
Talk Markets
Topics
ETFs
Stocks / Equities
Why the high growth investor may take a look at NATERA INC (NASDAQ:NTRA).
January 24, 2025
Exploring high growth characteristics of NATERA INC (NASDAQ:NTRA). A fundamental and technical analysis of (NASDAQ:NTRA).
Via
Chartmill
Why Top 4% Guardant Health Surged To A 13-Month High And Topped A Profit-Taking Zone
January 21, 2025
The company is working to expand the uses and reimbursement for its blood-based tests for cancer.
Via
Investor's Business Daily
Looking Into Natera's Recent Short Interest
January 20, 2025
Via
Benzinga
The Analyst Verdict: Natera In The Eyes Of 14 Experts
January 10, 2025
Via
Benzinga
Why NASDAQ:NTRA qualifies as a high growth stock.
January 03, 2025
Should you consider NATERA INC (NASDAQ:NTRA) for high growth investing?
Via
Chartmill
Moderna, GameStop And Snap Are Among Top Large-Cap Losers Last Week (Jan 13-Jan 17): Are The Others In Your Portfolio?
January 19, 2025
Eleven large-cap stocks were the worst performers in the last week. Short positions announced for FTAI, revenue updates for MRNA, and price forecasts changed for GME, SNAP, RKLB, NTRA, LLY, ICLR, BNTX,...
Via
Benzinga
The End Of The 60/40 Portfolio
January 17, 2025
Since bonds don't protect against stock declines, it's time for a different approach.
Via
Benzinga
Topics
Bonds
Exposures
Debt Markets
Nvidia To Rally Around 31%? Here Are 10 Top Analyst Forecasts For Friday
January 17, 2025
Via
Benzinga
Here Are Billionaire Stanley Druckenmiller's 5 Biggest Stock Holdings
January 09, 2025
Via
The Motley Fool
Exploring NASDAQ:NTRA's high growth characteristics.
December 13, 2024
Why the high growth investor may take a look at NATERA INC (NASDAQ:NTRA).
Via
Chartmill
Looking Into Natera's Recent Short Interest
December 02, 2024
Via
Benzinga
Analyst Expectations For Natera's Future
November 18, 2024
Via
Benzinga
Natera Analysts Increase Their Forecasts Following Upbeat Results
November 13, 2024
Via
Benzinga
Stanley Druckenmiller Dumps Street's Hottest AI Stocks — Here's What The Billionaire Investor Is Betting On Next
December 24, 2024
Druckenmiller's Duquesne Family Office sold Nvidia and Palantir stocks while increasing stake in Teva Pharmaceutical, signaling a shift in investment focus.
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Here Are Billionaire Stanley Druckenmiller's 5 Biggest Stock Holdings
December 21, 2024
Via
The Motley Fool
Stanley Druckenmiller's Top Holding Has Outperformed Its Sector By 252%
December 20, 2024
Billionaire Stanley Druckenmiller's latest large wager on biotech company Natera Inc has paid off, with his stake now exceeding $575 million.
Via
Benzinga
Here Are Billionaire Stanley Druckenmiller's 5 Biggest Stock Holdings
November 21, 2024
Via
The Motley Fool
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
November 13, 2024
Via
Benzinga
Earnings Scheduled For November 12, 2024
November 12, 2024
Via
Benzinga
How Is The Market Feeling About Natera?
November 05, 2024
Via
Benzinga
Exploring NASDAQ:NTRA's high growth characteristics.
November 04, 2024
NATERA INC (NASDAQ:NTRA) is a candidate for high growth investors. Here's why.
Via
Chartmill
Stocks Edge Higher, Dollar Hits 1-Year Peak, Bitcoin Soars To $93,000: What's Driving Markets Wednesday?
November 13, 2024
Wall Street rebounds on inflation report, with consumer discretionary and real estate sectors leading. Senator John Thune elected majority leader. U.S. dollar hits 1-year high.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Paymentus Posts Better-Than-Expected Earnings, Joins Dave, Honest Company, Natera, CAVA Group And Other Big Stocks Moving Higher On Wednesday
November 13, 2024
Via
Benzinga
Starbucks To $77? Here Are 10 Top Analyst Forecasts For Wednesday
November 13, 2024
Via
Benzinga
Stocks Fall On Tariffs Fears, Dollar Hits 6-Month Peak, Yen Tumbles: What's Driving Markets Tuesday?
November 12, 2024
Wall Street saw the first surge in risk aversion after Donald Trump's election victory last week, as concerns grew over potential tariffs and trade policy shifts spurred by the incoming...
Via
Benzinga
Topics
Government
World Trade
Exposures
Political
Tariff
3 Under-the-Radar Healthcare Companies
November 11, 2024
While established healthcare firms are among the most stable stocks in the sector, up-and-coming companies can offer the potential for greater gains.
Via
MarketBeat
Smaller Cap Biotechs Are In Season: How Are We Doing?
November 07, 2024
SMID biotech stocks still see a lot of speculative interest except for a brief sell-off on August 5 when the XBI touched $91.The XBI is near its 2024 high in the $103 range.
Via
Talk Markets
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.